NDC product
ARTISS Fibrin Sealant
NDC 0338-9641 · Baxter Healthcare Corporation
Key facts
| Product NDC | 0338-9641 |
|---|---|
| Proprietary name | ARTISS |
| Nonproprietary name | Fibrinogen Human, Human Thrombin |
| Substances | FIBRINOGEN HUMAN, HUMAN THROMBIN |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Labeler | Baxter Healthcare Corporation |
| Product type | PLASMA DERIVATIVE |
| Marketing category | BLA |
| Application number | BLA125266 |
| Pharmacologic classes | Blood Coagulation Factors [CS], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Factor Activity [PE] |
| Marketing start | Mar 19, 2008 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: